Guo, Y., Xue, L., Li, B., Lin, J., Yang, K., Fang, M., Ma, X., Xiao, S., Zhu, H., Zhu, Y. (2026). Phase II study of izalontamab (SI-B001) in combination with paclitaxel or docetaxel in patients with recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.6019